A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge
- PMID: 38005821
- PMCID: PMC10674279
- DOI: 10.3390/v15112143
A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge
Abstract
Classical swine fever (CSF) remains one of the most economically significant viral diseases affecting domestic pigs and wild boars worldwide. To develop a safe and effective vaccine against CSF, we have constructed a triple gene-deleted pseudorabies virus (PRVtmv)-vectored bivalent subunit vaccine against porcine circovirus type 2b (PCV2b) and CSFV (PRVtmv+). In this study, we determined the protective efficacy of the PRVtmv+ against virulent CSFV challenge in pigs. The results revealed that the sham-vaccinated control group pigs developed severe CSFV-specific clinical signs characterized by pyrexia and diarrhea, and became moribund on or before the seventh day post challenge (dpc). However, the PRVtmv+-vaccinated pigs survived until the day of euthanasia at 21 dpc. A few vaccinated pigs showed transient diarrhea but recovered within a day or two. One pig had a low-grade fever for a day but recovered. The sham-vaccinated control group pigs had a high level of viremia, severe lymphocytopenia, and thrombocytopenia. In contrast, the vaccinated pigs had a low-moderate degree of lymphocytopenia and thrombocytopenia on four dpc, but recovered by seven dpc. Based on the gross pathology, none of the vaccinated pigs had any CSFV-specific lesions. Therefore, our results demonstrated that the PRVtmv+ vaccinated pigs are protected against virulent CSFV challenge.
Keywords: CSFV challenge; PCV2 capsid; PRV trivalent vaccine; classical swine fever virus (CSFV); glycoproteins E2 and Erns; granulocytic monocyte-colony stimulating factor (GM-CSF); pig; pseudorabies virus; subunit vaccine; triple mutant; vaccine efficacy; vectored vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protects Pigs against PCV2b Challenge and Induces Serum Neutralizing Antibody Response against CSFV.Vaccines (Basel). 2022 Feb 16;10(2):305. doi: 10.3390/vaccines10020305. Vaccines (Basel). 2022. PMID: 35214763 Free PMC article.
-
Live Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Undergoes an Abortive Replication Cycle in the TG Neurons following Latency Reactivation.Viruses. 2023 Feb 8;15(2):473. doi: 10.3390/v15020473. Viruses. 2023. PMID: 36851689 Free PMC article.
-
Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.Immunol Lett. 2016 Jun;174:63-71. doi: 10.1016/j.imlet.2016.04.014. Epub 2016 Apr 22. Immunol Lett. 2016. PMID: 27113530
-
The challenges of classical swine fever control: modified live and E2 subunit vaccines.Virus Res. 2014 Jan 22;179:1-11. doi: 10.1016/j.virusres.2013.10.025. Epub 2013 Nov 6. Virus Res. 2014. PMID: 24211665 Review.
-
Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.Vet Q. 2000 Oct;22(4):182-8. doi: 10.1080/01652176.2000.9695054. Vet Q. 2000. PMID: 11087126 Review.
References
-
- KRAMER-SCHADT S., FERNÁNDEZ N., THULKE H.-H. Potential ecological and epidemiological factors affecting the persistence of classical swine fever in wild boar Sus scrofa populations. Mammal. Rev. 2007;37:1–20. doi: 10.1111/j.1365-2907.2007.00097.x. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources